Rafarma Pharmaceuticals, Inc. (RAFA) Announces Engagement of QualityStocks Investor Relations Services
10 Aprile 2013 - 2:00PM
Marketwired
Rafarma Pharmaceuticals, Inc. (PINKSHEETS: RAFA) announces today
that they have agreed with QualityStocks to be featured in The
Small Cap QualityStocks Daily Newsletter, QualityStocks Daily Blogs
and Message Boards. QualityStocks, based in Scottsdale, Arizona, is
a free service that collates data from hundreds of Small-Cap online
Investment Newsletters into one Daily Newsletter Report.
QualityStocks is dedicated to assisting emerging public companies
with their investor communication efforts.
Rafarma owns and operates a multi-profile pharmaceutical plant
that is able to produce all types and forms of medical drugs in
various pharmacological groups. The plant was constructed in the
territory of a special industrial economic zone in Terbuny of the
Lipetsk region of Russia. The project was initiated by the Zdorovie
Foundation and is considered one of the grandest projects of the
Russian medical industry in the last few years.
Michael McCarthy, Managing Director of QualityStocks, stated,
"We have conducted extensive due diligence and are very excited to
inform the investment community of Rafarma's corporate strategy and
ongoing progress. Last month our team traveled over 6,000 miles to
visit the company's 270,000 square-foot plant and take on-site
video footage. We will be releasing a series of high-definition
videos that fully encapsulate Rafarma's state-of-the art
manufacturing facility and relay its legitimacy, opportunity, and
enormity in the best way possible."
The first video produced by QualityStocks can be viewed at
http://Video.QualityStocks.net.
QualityStocks has also put together a detailed, 10-page investor
kit as well as a 34-slide presentation, both of which can be found
at http://RAFA.QualityStocks.net.
Dave Anderson, CEO of Rafarma Pharmaceuticals, stated, "RAFA has
a unique and solid business foundation, and appreciates the
opportunity to sponsor the QualityStocks Newsletter, Video and
Blogs. QualityStocks is providing a much needed service in the
micro-cap and small-cap markets."
About Rafarma
Pharmaceuticals, Inc. (RAFA)
Operating from a new 270,000 square-foot state-of-the-art
manufacturing and distribution facility in Russia, Rafarma
Pharmaceuticals produces generic antibiotics and specialty
pharmaceuticals in addition to its own line of proprietary products
that are approved by the Ministry of Health of Russian Federation.
For the last three years, the Russian Government has been highly
focused on bolstering the development of nation's domestic
pharmaceutical industry. Rafarma Pharmaceuticals' mission is to
work with the auspices of aggressive federal initiatives to
fast-track the modernization of Russia's pharmaceutical
industry.
For more information on Rafarma Pharmaceuticals, visit:
http://RAFA.QualityStocks.net
About QualityStocks
Small Cap Stock Newsletter QualityStocks is a free service that
collects data from hundreds of Small-Cap and Micro-Cap online
Investment Newsletters into one free Daily Newsletter Report.
QualityStocks also utilizes social media and networking to maintain
constant communication with its rapidly growing audience. To date,
QualityStocks has more than one million users following various
social networking accounts.
QualityStocks is committed to connecting subscribers with
companies that have huge potential to succeed in the short and
long-term future. It is part of our mission statement to help the
investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to
learn more about investing in these companies as well as find and
evaluate them.
For more information, visit www.QualityStocks.net
Forward-Looking Statements:
This release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended
and Section 21E of the Securities Exchange Act of 1934, as amended.
All forward-looking statements are inherently uncertain as they are
based on current expectations and assumptions concerning future
events or future performance of the company. Readers are cautioned
not to place undue reliance on these forward-looking statements,
which are only predictions and speak only as of the date hereof. In
evaluating such statements, prospective investors should review
carefully various risks and uncertainties identified in this
release and matters set in the company's SEC filings. These risks
and uncertainties could cause the company's actual results to
differ materially from those indicated in the forward-looking
statements.
Contact: Astra Thomas QualityStocks Scottsdale, Arizona
www.QualityStocks.com 480.374.1336 editor@QualityStocks.net
Grafico Azioni Rafarma Pharmaceuticals (PK) (USOTC:RAFA)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Rafarma Pharmaceuticals (PK) (USOTC:RAFA)
Storico
Da Giu 2023 a Giu 2024